December 25, 2024 06:38 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Former home secy Ajay Kumar Bhalla appointed Manipur Guv amid ethnic violence resurgence | Five soldiers killed, several injured as Army truck falls into Poonch gorge | Allu Arjun quizzed by police in Pushpa 2 stampede case | Wanted Indian drug smuggler killed in the US | Congress leader files complaint against Allu Arjun for 'insulting police' in Pushpa 2: The Rule | Ahead of Jaishankar's US visit, foreign secretary Vikram Misri meets top US diplomats | India refrains from commenting on extradition request for ousted Bengladeshi PM Sheikh Hasina | I don't blame Allu Arjun, ready to withdraw case: Pushpa 2 stampede victim's husband | Indian New Wave Cinema Architect Shyam Benegal dies at age 90 | Cylinder blast at a temple in Karnataka's Hubbali injures nine people
SII buys 50 pc stake in pharma packaging firm Schott Kaisha

SII buys 50 pc stake in pharma packaging firm Schott Kaisha

Aug 18, 2021, at 06:41 am

Pune/IBNS: Pune-based manufacturer of AstraZeneca vaccine, Covishield, Serum Institute of India (SII) has acquired a 50 per cent stake in SCHOTT Kaisha to become SCHOTT's joint venture partner and secure the pharma packaging supply, the pharma company announced on Tuesday.

Boris Johnson announces Serum Institute of India to invest 240 million pounds in UK

Boris Johnson announces Serum Institute of India to invest 240 million pounds in UK

May 04, 2021, at 05:09 pm

London: British PM Boris Johnson has announced the Serum Institute of India (SII), the manufacturers of COVID-19 vaccine Covishield, will be investing 240 million pounds in the United Kingdom through the opening of a new sales office, media reports said.